InvestorsHub Logo
Followers 4
Posts 180
Boards Moderated 0
Alias Born 05/12/2012

Re: Rkmatters post# 142

Thursday, 06/16/2016 5:59:41 PM

Thursday, June 16, 2016 5:59:41 PM

Post# of 1415
Yes, I agree that DMPI is severely undervalued right now.

I don't believe the price you mention includes the value for front-line GBM, which I have confidence in their efficacy for. Nor does the price include the opportunity surrounding NSCLC (non small cell lung cancer). Just those two elements could turn this valuation closer to the 1 billion dollar amount, IMHO.

Not to mention the other molecules they have ready to roll out in the same way they did with val-083.

Long term hold will be well worth it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KTRA News